BridgeBio Pharma BBIO
NASDAQ BBIO
$67.74 +0.19 (+0.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Work In Process (2025 - 2026)

Updated

BridgeBio Pharma (BBIO) posted Work In Process of $16.7 million for Q2 2026, compared with $1.07 million a year earlier and up 59.3% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Work In Process (2025 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma's Work In Process came in at $6.1 million.

  • According to Business Quant data, Work In Process for the three prior quarters was $10.49 million (Q1 2026), $6.1 million (Q4 2025) and $4.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 BridgeBio Pharma 13.26 Bn 10.37 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.70 Mn
Mar 31, 2026 10.49 Mn
Dec 31, 2025 6.10 Mn
Sep 30, 2025 4.13 Mn
Jun 30, 2025 1.07 Mn
Mar 31, 2025 1.32 Mn
API Access

BridgeBio Pharma Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=BBIO&period=max&api_key=YOUR_API_KEY